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We recently reported (Clewell et al., 1972) on an inhibitory effect of rifampicin on 
Co1 E 1 plasmid replication. The present study represents a further characteriza- 
tion of this phenomenon as well as a study of the effects of two other known 
inhibitors of RNA synthesis, streptolydigin and actinomycin D. 
During treatment of cells with chloramphenicol the colicinogenic factor El 
(Co1 El) continues to replicate for more than ten hours. During this time 4 to 
5 S RNA is also synthesized. When varying concentrations of rifampicin were 
inchIded during chloramphenicol treatment, inhibition of plasmid DNA synthe- 
sis correlated very closely with inhibition of cellular RNA synthesis. Similar 
experiments testing the effects of streptolydigin and actinomycin D (during 
chloramphenicol treatment) showed that cellular RNA synthesis was at least 
100 times more sensitive to these drugs than was plasmid DNA synthesis. 
When actively growing cells (i.e. cells not treated with chloramphenicol) were 
treated with a high concentration of rifampicin (250 pg/ml), chromosomal DNA 
synthesis continued to an extent representing about a 50% increase in DNA, 
while plasmid DNA synthesis appeared to stop abruptly. 
1. Introduction 
The colicinogenic factor El, in Escherichia co& has several features which make it 
an attractive system for studying DNA replication. First, it is a relatively small 
circular DNA molecule (mol. wt 4.2 x 106), present to the extent of 20 to 30 copies 
per cell, and it can be isolated by simple and rapid procedures (Bazaral & Helinski, 
1968; Clewell & Helinski, 1972). Second, it has been found to replicate semiconserva- 
tively in the presence of high levels of chloramphenicol, long after chromosomal 
DNA replication has ceased (Clewell & Helinski, 1972; Clewell, 1972). During this 
time the average rate of plasmid DNA synthesis increases until, after two to four 
hours, a maximum rate is achieved corresponding to about eight times the normal 
average rate that would be required to double the amount of plasmid DNA per cell 
in one generation (Clewell, 1972). Synthesis continues for 10 to 15 hours with a net 
accumulation of about 3000 copies of Co1 El DNA per cell. 
We are currently making use of this system to examine the effects of a number of 
antibiotics on DNA replication, and have reported recently on a potent inhibitory 
effect of rifampicin (Clewell et al., 1972). Since rifampicin is a specific inhibitor of 
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DNA-dependent RNA polymerase, and since plasmid replication is rifampicin- 
resistant in strains containing rifampicin-resistant RNA polymerase, we suggested 
that at least the beta subunit of the polymerase (which is the part that interacts with 
rifampicin) may be in some way closely involved in DNA replication. 
In this paper we report a more detailed examination of the effects of rifampicin 
on Co1 El DNA replication, both in chloramphenicol-treated cells and in actively 
growing cells. Studies of the inhibitory effects of rifampicin, streptolydigin and actino- 
mycin D on plasmid DNA synthesis and cellular RNA synthesis during chloram- 
phenicol treatment reveal that RNA and DNA syntheses are equally sensitive to 
rifampicin, whereas RNA synthesis is at least 100 times more sensitive than DNA 
synthesis to streptolydigin and actinomycin D. 
2. Materials and Methods 
(a) Bacterial strains and me&u 
E. coli K12 strain CR34 (Co1 El) (auxotrophic for Thr, Leu, vitamin Bl and Thy) 
(Okada et al., 1960) and a streptolydigin-sensitive derivative (Slyd-1) were used in this 
study. Each strain harbors the Co1 El plasmid DNA, which was originally transferred by 
conjugation from E. coli K30. An MS-glucose-Caaamino acids (Difco) medium containing 
thymine (5 pg/ml) and vitamin Bl (2.5 pg/ml) (Clewell, 1972) was used for all of the experi- 
ments in this work except the [sH]leucine-labeling experiment. In the latter, the Cas- 
amino acids were replaced by separate addition of leucine (25 pg/ml) and each of the other 
required amino acids (50 pg/ml). Cell growth was at 37’C and turbidity was monitored 
using a Klett-Summerson calorimeter. 
Slyd-1, the streptolydigin-sensitive mutant, was derived as follows: CR34 (Co1 El) 
cells were treated for 15 min with nitrosoguanidine (30 pg/ml) in Penassay broth (Difco) 
at 37°C. Cells were pelleted and resuspended in Penassay broth, allowed to segregate 
(overnight growth) and then treated for 6 h with penicillin G (2000 units/ml) and strepto- 
lydigin (30 pg/ml). Cells were plated and colonies were tested for streptolydigin sensitivity 
on Penassay broth-agar containing 50 rg streptolydigin/ml. Streptolydigin sensitivity 
was observed in 2 out of 40 colonies picked. 
(b) Materials 
Reagents and sources were as follows : Brij -58 from Emulsion Engineering Inc. ; sodium 
deoxycholate from Difco Laboratories ; sodium dodecyl sulfate from Fisher Scientific: 
egg white lysozyme, pronase, ethidium bromide, penicillin G, rifampicin (rifampin) 
(Lepetit), tetracycline and streptomycin sulfate from Calbiochem ; chloramphenicol from 
Parke, Davis & Co.; actinomycin D from Merck, Sharp & Dohme; streptolydigin was a 
gift from the Upjohn Co. ; puromycin from Nutritional Biochemical Corp. ; C&l (optical 
grade) from Schwartz Bioresearch, Inc. ; [methyZ-3H]thymine (11.7 Ci/mmol), [2J*C]thy- 
mine (55.8 mCi/mmol), [B-“Hluridino (26.0 Ci/mmol) and L-[4,5-3H]leucine (5.0 Ci/mmol) 
from New England Nuclear. 
(c) Preparation of lysatee 
The lysing procedure has been described in detail previously (Clewell & Helinski, 
1969,197O). It involves the lysis of EDTA-lysozyme spheroplasts with a detergent mixture 
of Brij-58 and sodium deoxycholate. A 48,000 g centrifugation (for 25 min) of the crude 
lysate pellets a major portion of the chromosomal DNA, leaving plasmid DNA in the 
supernatant. This supernatant is referred to as cleared lysate. Crude lysates and cleared 
lysates can be frozen (-70°C) until ready for further use. The lysis procedure used for 
RNA extraction is described below. 
(d) Ultracentrifugation procedures 
Dye-buoyant, density equilibrium centrifugation and sucrose density gradient centri- 
fugation were done as described previously (Clew011 & Helinski, 1970; Clewell, 1972; 
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Clew& et al., 1972). When RNA was analyzed, the sucrose gradients contained 0.15 M- 
NaCl, O-005 nl-disodium EDTA and O-03 M-Tris, pH 8-O. 
(e) Extraction of RNA 
Cells labeled with [3H]uridine were harvested and resuspended in 1 ml of 25% sucrose 
(0.05 M-Tris, pH 8.0). A 0*2-ml portion of lysozyme (5 mg/ml in 0.05 M-Tris, pH 8.0) was 
added and, after 5 min at 25”C, 0.2 ml of O-007 M-disodium EDTA (pH 8-O) was added. 
Upon incubation for another 5 min (25”C), 1.6 ml of 2.0% sodium dodecyl sulfate (in 
0.05 nf-Tris (pH 8.0), 0.03 M-MgCl,) was added. An equal volume of a phenol/chloroform 
mixture (2: l), saturated with Tris/EDTA/NaCl buffer (0.03 M-Tris, 0.005 M-disodium 
EDTA (pH 8-O), O.O5M-NaCl), was added to the lysate and mixed vigorously with a Vortex. 
The aqueous phase was removed (after low-speed centrifugation) and the procedure re- 
peated. The aqueous phase was then adjusted to 0.1 M-NaCl, after which the RNA was 
precipitated with 2 volumes of 95% ethanol. The precipitate was pelleted and redissolved 
in 1.0 ml of Tris/NaCl/EDTA buffer. 
(f ) Counting of radioisotopes 
Samples were premed and counted aa described previously (Clewell & Helinski, 
1970) in a Beckman LS250 liquid scintillation system. 
3. Results 
(a) Comparison of cellukzr RNA synthesis with plasmid DNA synthesis during 
antibiotic treatment 
While previously we showed (ClewelI et al., 1972) that rifampicin inhibited Co1 El 
replication as well as cellular RNA synthesis in chloramphenicol-treated cells, the 
exact drug sensitivity of these two processes was not quantitated. The following 
experiments were designed to determine the levels of sensitivity to rifampicin as well 
as to two other known inhibitors of RNA synthesis. 
Camt was added to a culture of CR34 (Co1 El) cells that had been growing for 
several generations in log phase. After 3.5 hours, the culture was divided into 4-ml 
portions, to each of which was added a specified quantity of rifampicin. After 30 
minutes a mixture of [3H]uridine and [14C]thymine was added to each portion; 
after 15 minutes of labeling, NaN, was added and the cells were plunged into an ice 
bath. The cells were lysed and samples were removed to determine the amount of 
radioactivity incorporated into acid-precipitable material. The results are shown in 
Figure 1. A correlation between the incorporation of [3H]uridine and [14C]thymine 
at different concentrations of rifampicin is readily apparent. The concentration of 
rifampicin required for 50% inhibition was about 0.1 pg/ml (1.2 x lo- 7 M) in each 
case. On the basis of 14C counts (DNA) in the crude lysates, a “maximum” inhibition 
of about 75% is evident. The remaining 25% represents rifampicin-resistant DNA 
synthesis. This DNA is not of a covalently closed nature, as is apparent when portions 
of lysates were analyzed in dye-buoyant density gradients (Clewell et al., 1972) (Fig. 
2). Covalently closed circular Co1 El DNA bands, under these conditions, at a higher 
density than linear or nicked circular DNA (Radloff et al., 1967). It is evident that the 
synthesis of the DNA found in the less dense band is unaffected by rifampicin, where- 
as closed circular DNA is not made at 10 pg rifampicinlml. In separate experiment,s, 
sucrose density gradient analyses of material in the less dense band indicate that 
about 80% of this DNA is chromosomal, the remainder being rifampicin-sensitive, 
t Abbreviation used: Cam, ohlorampheniool. 
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Fm. 1. Comparison of the effect of various concentrations of rifampicin on plasmid DNA 
synthesis and cellular RNA synthesis during treatment with Cam. E. coli CR34 (Co1 El) cells 
(47 ml) were grown for several generations in log phase to a point representing about 3 x 10s 
cells/ml. Cam (160 &ml) was added and, after 3.6 h, the culture was divided into 4-ml portions. 
To each was added 0.4 ml of rifampicin (various concentrations) in water and, after 30 min, 
0.3~ml portions of an aqueous solution containing 20 @i (0.19 pg) [3H]uridine and 10 $Zi (22 fig) 
[‘%]thymine. After a 16.min labeling period, NaN, was added (to 0.06 M) and the cells were 
plunged into an ice bath. Cells were harvested, lysed (by the Brij-deoxycholate procedure) and 
O.l-ml samples (in duplicate) were used to determine the level of 14C and 3H present as trichloro- 
acetic acid-precipitable material. The results (averages of duplicate determinations) are shown in 
the Figure. The [l*C]thymine incorporation is plotted both as reflecting total cts/min in the crude 
lysate and after correction for residual chromosomal DNA synthesis by subtracting the cts/min 
obtained for the 10 pg/ml (rifampicin) point from each of the other points. The level of radioactivity 
in the control sample was 129,266 cts/min of sH and 982 cts/min of ‘*C. (a) Incorporated [3H]uri- 
dine; (0) incorporated [l’C]thymine; (0) incorporated [l%]thymine (corrected). 
non-supercoiled Co1 El DNA (representing less than 5% of the total plasmid DNA in 
the lysate). When the radioactivity present in the “light” band is subtracted from 
the total l*C counts in each crude lysate, a value is obtained which should correspond 
closely to covalently closed plasmid DNA. Such corrected values are plotted separately 
in Figure 1 and generate a curve which is superimposed on that representing incor- 
porated [3H]uridine. 
Using our streptolydigin-sensitive strain, Slyd-1, we did an experiment similar 
to the above except that the effect of streptolydigin was analyzed. The results shown 
in Figure 3(a) indicate that, unlike rifampicin, more than 100 times as much strepto- 
lydigin is required to inhibit DNA synthesis as is required to inhibit RNA synthesis. 
A streptolydigin concentration of about 0.5 pg/ml (8.3 x lo- 7 M) provided 50% 
inhibition of cellular RNA synthesis, whereas greater than 50 pg/ml was necessary 
for a similar inhibition of DNA synthesis. Although there appears to be some selec- 
tive inhibition of synthesis of DNA isolated as closed circular molecules (Fig. 3(c)), 
concentrations greater than 100 pg/ml appear also to affect synthesis of DNA found 
in the less dense band. It is interesting that the concentration of streptolydigin that 
provides 50% inhibition of cell RNA synthesis is about tenfold less than that reported 
for the in vitro inhibition of RNA polymerase (Cassani et al., 1970). The reason for 
this is not apparent but may simply reflect differences between in vivo and in vitro 
conditions. 
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Fro. 2. Dye-buoyant density centrifugation of crude lysates of cells treated with chloramphenicol 
and rifampicin. The lysates (1 ml) were centrifuged to equilibrium in C&l buoyant density 
gradients containing ethidium bromide. Density increases from right to left: (a) control cells; 
(b) and (c) cells of Fig. 1 that had been treated with 0.1 and IO.0 pg rifampicin/ml, respectively. 
The arrow represents the banding position of chromosomal DNA. 
Actinomycin D was tested in a similar manner (see Fig. 3(b) and (d)) and was found 
to be like streptolydigin. While 0.1 pg/ml (8.0 x lo- 8 M) provides about 50% inhibi- 
tion of RNA synthesis, close to 10 rug/ml is required for a similar inhibition of DNA 
synthesis. As in the case of streptolydigin, dye-buoyant density analyses (Fig. 3(d)) 
indicate some selective inhibition of Co1 El DNA but not to the extent seen with 
rifampicin. 
(b) Nature of cellular RNA synthesis during extensive chbrampheniwl 
treatment 
Since the above experiments have involved measurements of cellular RNA synthe- 
sis during highly abnormal conditions (i.e. after several hours of Cam treatment), 
it was of interest to know more about the RNA being produced, with regard to both 
over-all rate of synthesis and the nature of the RNL4. 
Experiments involving pulse-labeling with [3H]uridine (lo-min pulses) at various 
time points after the addition of Cam have indicated (data not shown) that CR34 
(Co1 El) cells synthesize RNA at a rate which, within 30 minutes, increases by 20% 
and remains at this level for about two hours. After four hours the rate is decreased 
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FIQ. 3. Comp8rison of the effects of various concentrations of streptolydigin and actinomycin D 
on plasmid DNA synthesis and cellular RNA synthesis during treatment with Cnn. E. coli CR34 
(Co1 El) cells were grown and treated in 8 manner similar to that described in the legend to Fig. 1, 
except thet samples (0.1 ml) of streptolydigin or actinomycin D (various concentrations) dissolved 
in dimethyl sulfoxide were added to e8ch 4.ml portion of Gem-treated cells. Control cells received 
0.1 ml dimethyl sulfoxide containing no drug. The streptolydigin-sensitive strain Slyd-1 w&s 
used for the streptolydigin experiment. In the experiment using actinomycin D, d&odium 
EDTA w8s added (fin81 concn of 0.01 M) 6 min before division of the culture into 4-ml portions. 
The results of determinations of i4C and 3H radio8ctivity in the crude lysates (average of duplicate 
(in the o&se of streptolydigin) or triplicate (in the case of actinomycin D) determinations on O-l- 
ml portions) 8re shown above where (8) 8nd (b) represent streptolydigin and actinomycin D- 
treated cells, respectively. The level of radioactivity in the control sample ~8s 41,968 cts/min of 
sH and 128 cts/min of “C in the c8se of streptolydigin experiment; end 42,640 cts/min of 3H and 
492 cts/min of “C in the 8&inomycin D experiment. -O-O--, Incorporated [3H]uridine; 
--O--O--, incorporated [‘*C]thymine. 
The above lysetes were 8n8lyzed by centrifugetion to equilibrium in CsCl gradients aontaining 
ethidimn bromide in 8 manner similer to that of Fig. 2. (c) and (d), respectively, represent lysrttes 
of streptolydigin and ectinomycin D-treated cells. The consent&ion of drug used is indiceted in 
eeoh panel. 
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Pm. 4. Sedimentation analyses of RNA synthesized before and after treatment of cells with 
Cam. A culture of CR34 (Co1 El) cells (44 ml) in MS-Casamino acids medium was grown to approx. 
3 x lo* cells/ml. A 20.ml portion of the cells W&s removed and labeled for 30 min with 0.2 mCi of 
[3H]uridine 8fid plunged into an ice bath. C8m (176 ag/ m 1) w&s added immedi8tely to the remain- 
der of the culture. After 3.6 h of exposure to the drug, another 20-ml portion W&S removed 8nd 
incubated similarly with [3H]uridine for 30 min. RNA was extracted from each portion of cells, 
after which 0.2 ml of each sample WBS centrifuged through 6 to 20% sucrose density gradients 
(from right to left) in a Beckmen SW60.1 rotor (16%) at 48,000 revs/mm for 120 min. (a) Cells 
not treated with Csm; (b) treated cells. 
to a level similar to that immediately before a Cam addition. After six and eight hours, 
the rate is decreased to 50 and 5%, respectively, of the initial rate. 
To determine the nature of the cellular RNA synthesized, a portion of cells was 
labeled with r3H]uridine before treatment while another portion was labeled follow- 
ing 3.5 hours of exposure to Cam. RNA was extracted and examined on sucrose 
density gradients. As shown in Figure 4, the RNA labeled before Cam treatment has 
a relatively normal pattern with three major peaks, which sediment at 23 S, 16 S 
and 4 to 5 S (corresponding to ribosomal and tRNA). After Cam treatment the pattern 
looks quite different, with a major decrease in the level of 23 S and 16 S RNA; while 
the slower sedimenting material appears not to be affected. A significant amount of 
the higher molecular weight material continues to be synthesized, but it appears 
rather heterogeneous. Thus, the inhibition of cellular RNA that is observed with 
increasing concentrations of antibiotics (see section (a) above) involves RNA that is 
relatively small (i.e. 4 to 5 S). 
(c) Inhibition of protein synthesis 
In attempts to strengthen the view that inhibition of plasmid DNA synthesis by 
rifampicin is not the result of an indirect inhibition of a small amount of protein that 
610 D. B. CLEWELL AND B. G. EVENCHIK 
escapes inhibition by Cam, several types of experiments were done. First, it was 
found that concentrations of Cam as high as 1000 pg/ml did not significantly alter the 
rate at which Co1 El DNA was synthesized. Second, we observed that puromycin 
(1000 pg/ml), tetracycline (100 pg/ml) and streptomycin (200 pg/ml) when present 
independently in the medium behaved similarly to Cam in allowing a selective continu- 
ation of Co1 El DNA synthesis, although in the case of tetracycline and streptomycin 
the rates of replication were only about 30% of that seen with Cam (as measured by 
observing the relative amounts of covalently closed circular DNA appearing in a 
dye-buoyant density gradient after treating uniformly labeled ( [3H]thymine) cells 
with drug for 4 to 5 hours). When tetracycline (100 pg/ml) was mixed with Cam 
(200 pg/ml), the amount of plasmid DNA synthesis was at approximately the same 
level as that seen when tetracycline alone was used. Similarly, when puromycin 
(1000 pg/ml) was mixed with Cam (200 pg/ml), the rate of replication was no different 
from that of cells treated with either puromycin or Cam alone. 
In a third type of experiment, protein synthesis was examined directly by measur- 
ing the relative amounts of [3H]leucine incorporated into acid-precipitable material 
before Cam treatment of cells, as well as after a four-hour exposure to the drug. 
Incorporation was measured also in cells treated with rifampicin (1 pg/ml) during the 
last 0.5 hour of a four-hour treatment with Cam. It was found that inhibition was 
approximately 99% in cells treated with Cam, and no further inhibition was evident 
when rifampicin was also present. However, the background level of radioactivity 
in these experiments was relatively high and variable, making it difficult to assess 
accurately degrees of inhibition much greater than 98 to 99”/. Thus, if rifampicin 
did in fact have an additional inhibitory effect on protein synthesis, we probably 
would not detect it by this method. 
04 Effect of f P ri am icin on jdasmid replication in actively growing cells 
When actively growing cells were treated with a low level of rifampicin (1 pg/ml), 
which effectively inhibits Co1 El DNA synthesis in cells pretreated with Cam, 
we failed to observe any inhibition of either chromosomal or plasmid DNA 
synthesis. However, high concentrations of rifampicin produced a well-pronounced 
inhibition. 
A culture of CR34 (Co1 El) cells, grown for several generations in the presence of 
[l%]thymine to prelabel DNA, was divided into two equal portions and shifted 
(Clewell, 1972) to media containing [3H]thymine in place of [l*C]thymine. One medium 
contained 250 pg rifampicin/ml, while the other served as a control. When the control 
culture had undergone one generation of growth (50 min), both cultures were chilled 
rapidly in an ice bath. Crude lysates were prepared and samples were counted to 
determine the ratio of 3H to l*C. Since plasmid DNA normally represents less than 
2% of the total DNA (Clewell & Helinski, 1970), this ratio reflects the extent of 
replication of chromosomal DNA following the medium shift. In the case of the 
control, this ratio should correspond to approximately one doubling of DNA. To 
determine the extent of replication of plasmid DNA, the lysates were centrifuged 
at 48,000 g for 20 minutes to remove most of the chromosomal DNA, and the super- 
natants (cleared lysates) were analyzed on sucrose density gradients, so that the 
ratio of 3H to l*C in plasmid DNA could be determined. Figure 5 shows the results of 
sucrose density analyses of the two lysates. Co1 El DNA is seen as a peak centered 
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FIG. 6. Sedimentation analyses of lysates of cells with and without rifampicin treatment. A 
40-ml culture of CR34 (Co1 El) cells grown for several generations in the presence of [14C]thymine 
(2.0 $X/4.6 rg/ml) wms divided into 2 equal portions, pelleted and resuspended in 2 separate 
media (20 ml each) containing [3H]thymine (26 @i/6*2 pg/ml) in place of the [i*C]thymine. One 
medium contained 260 pg rifampicin/ml while the other served 8s a control. When the turbidity 
of the control oulture had doubled (60 min), both cultures were chilled rapidly in an ice bath. 
Cleared lysates were prepared and sedimented through 6 to 20% sucrose density gmdients (from 
right to left) in 8 Be&men SW60.1 rotor (16°C) at 48,000 revs/min for 136 min. (a) Cleared lysate 
of control cells not treated with rifampioin; (b) cleared lysate of cells treated with rifampicin. 
-a-+--, sH radioactivity; --O--O--, 14C radioactivity. 
around fraction 15. The incorporation of 3H counts into Co1 El DNA in rifampicin- 
treated cells is less than 5% that of the control whereas, on the basis of radioactivity 
in the crude lysates, chromosomal DNA synthesis in treated cells was 51% that of 
the control. Similar experiments involving samples of rifampicin-treated cells taken 
at one, two and four hours indicate that chromosomal DNA synthesis behaves as 
though current rounds of replication were being completed (within about 1 h) prior 
to termination (Maalse & Hanawalt, 1961), whereas Co1 El synthesis appears to stop 
abruptly. 
The requirement for a relatively high concentration of rifampicin to affect actively 
growing cells agrees with the data of others, indicating that the rifamycins are only 
weakly active against Gram negative bacteria for permeability reasons (Puresz et 
al., 1966). It is not clear why cells treated with Cam are sensitive to much lower 
concentrations of rifampicin than actively growing cells. Apparently, Cam treatment 
results in an alteration of the cell wall-membrane complex, resulting in an increase 
in the permeability of the drug. 
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4. Discussion 
In a previous report (Clewell et al., 1972) we suggested that the RNA involved in 
Co1 El replication may serve as a “primer”. This notion is further strengthened by 
a recent report by Blair et al. (1972), which showed that a relatively large percentage 
of the Co1 El DNA molecules that accumulated during extensive treatment of cells 
with Cam were both alkali and RNase sensitive. By such treatment, the supercoils 
were observed to open to a relaxed configuration with an “opening ” in only one 
strand. This was interpreted to mean that under these conditions (extensive Cam 
treatment) Co1 El DNA contained a segment of RNA integrated in one strand. It 
was postulated that ribonucleotides normally were (after serving as a primer for DNA 
synthesis) removed and replaced by DNA, but that under the abnormal condition 
presented by the long incubation in the presence of Cam there is a failure in 
the “ribonucleotide-removal” (repair) mechanism. The replication process was 
required for generation of the RNase-sensitive circles, since rifampicin blocked their 
appearance. 
We have shown here that in the presence of Cam the degree of inhibition of plasmid 
DNA synthesis by various concentrations of rifampicin is the same as the degree of 
inhibition of cellular RNA synthesis. In contrast, streptolydigin and actinomycin D 
block Co1 El DNA synthesis only at concentrations at least loo-fold higher than that 
required to inhibit cellular RNA synthesis. The difference may be related to the fact 
that rifampicin blocks the initiation of RNA synthesis but does not inhibit growth 
of previously initiated RNA chains, whereas streptolydigin and actinomycin D 
interfere with strand elongation, respectively, by binding directly to RNA polymerase 
and to the DNA template (see Goldberg I% Friedman, 1971; Wehrli & Staehelin, 
1971). In the case of actinomycin D, the difference in sensitivity between cellular 
RNA synthesis and the synthesis of the putative primer RNA may reflect a small 
template size for the primer (Bleyman & Woese, 1969) and/or a low template G + C 
content (see Goldberg & Friedman, 1971). In the case of streptolydigin, which slows 
down elongation by binding reversibly to RNA polymerase (Cassani et al., 1970; 
Heil & Zillig, 1970), the lower sensitivity may be attributed either to a modifica- 
tion of the RNA polymerase involved in plasmid replication or to a specific compart- 
mentalization of the transcription complex making streptolydigin binding difficult 
(compartmentalization would not necessarily be a barrier to rifampicin, since the 
latter could bind to the enzyme prior to binding of the enzyme to DNA). 
In vitro studies on the coliphage Ml3 (Wickner et al., 1972) and $X174 (Schekman 
et al., 1972) systems strongly suggest that the synthesis of complementary DNA on 
the viral single-stranded circular template is dependent on the synthesis of a primer 
RNA. In the case of coliphage M13, rifampicin and streptolydigin block synthesis, 
while in the case of $X174, the synthesis of the RNA primer is resistant to these 
drugs (Schekman et al., 1972). Both systems, however, are sensitive to actinomycin 
D in vitro, a phenomenon possibly related to a hairpin double-helical region in the 
single-stranded templates where the RNA may be synthesized (Schekman et al., 
1972). As in the case of $X174, synthesis of RNA-primer of Okazaki fragments 
(Sugino et al., 1972) in E. coli is resistant to rifampicin. Thus, there must be more than 
one type of RNA polymerase activity in the cell. Whether or not these activities 
simply represent modified forms of a common core protein remains to be determined ; 
however, it is conceivable that there are many modified forms of cellular RNA 
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polymerase involved in many specific transcription events, one of which may involve 
a rifampioin-sensitive, streptolydigin-resistant activity involved in the synthesis of 
Co1 El primer RNA. 
The studies involving actively growing cells demonstrated that rifampioin effeo- 
tively inhibits the incorporation of radioactive thymine into Co1 El DNA, while 
allowing ohromosomal DNA to complete the current round of replication. We view 
this as a blocking of the initiat’ion of plasmid replication which appears as an imme- 
diate shut-off of the incorporation of label because plasmid replication, once started, 
is rapidly completed. That is, if a Co1 El DNA molecule replicates at the same DNA 
strand-elongation rate as that of chromosomal DNA, then it should take only a few 
seconds to complete a round of replication. It has, in fact, been determined that the 
strand elongation time is relatively short (Bazaral & Helinski, 1970; Clewell, 1972). 
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